Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response

KR Chien, KU Knowlton, S Chien - The FASEB Journal, 1991 - Wiley Online Library
Studies from both in vivo and in vitro model systems have provided an initial skeleton of the
potential signaling pathways that might regulate cardiac genes during growth and …

Viral myocarditis: from the perspective of the virus

T Yajima, KU Knowlton - Circulation, 2009 - Am Heart Assoc
preventive measures for virus-mediated heart disease could be instituted. Phase 1 is
defined as the period of time when active replication of live virus is occurring within the …

Transcriptional regulation during cardiac growth and development

KR Chien, H Zhu, KU Knowlton… - Annual review of …, 1993 - annualreviews.org
During the last decade, a variety of morphological, physiological, and biochemical studies
have provided an improved definition of the alterations in myocardial structure and function …

Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.

HA Rockman, RS Ross, AN Harris… - Proceedings of the …, 1991 - National Acad Sciences
To study the mechanisms that activate expression of the atrial natriuretic factor (ANF) gene
during pressure-induced hypertrophy, we have developed and characterized an in vivo …

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy

C Badorff, GH Lee, BJ Lamphear, ME Martone… - Nature medicine, 1999 - nature.com
Enteroviruses such as Coxsackievirus B3 can cause dilated cardiomyopathy, but the
mechanism of this pathology is unknown. Mutations in cytoskeletal proteins such as …

[HTML][HTML] Multiomics study of nonalcoholic fatty liver disease

G Sveinbjornsson, MO Ulfarsson, RB Thorolfsdottir… - Nature …, 2022 - nature.com
Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed
a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and …

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a …

WH Self, U Sandkovsky, CS Reilly, DM Vock… - The Lancet Infectious …, 2022 - thelancet.com
Background We aimed to assess the efficacy and safety of two neutralising monoclonal
antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus …

Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism

J Ghouse, V Tragante, G Ahlberg, SA Rand… - Nature Genetics, 2023 - nature.com
We report a genome-wide association study of venous thromboembolism (VTE)
incorporating 81,190 cases and 1,419,671 controls sampled from six cohorts. We identify 93 …

A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3

KU Knowlton, ES Jeon, N Berkley, R Wessely… - Journal of …, 1996 - Am Soc Microbiol
Coxsackievirus B3 (CVB3) infections induce myocarditis in humans and mice. Little is known
about the molecular characteristics of CVB3 that activate the cellular immunity responsible …

Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle

ML Bang, X Li, R Littlefield, S Bremner, A Thor… - The Journal of cell …, 2006 - rupress.org
Nebulin is a giant modular sarcomeric protein that has been proposed to play critical roles in
myofibrillogenesis, thin filament length regulation, and muscle contraction. To investigate the …